Pharmaxis

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Pharmaxis Limited (PXS) is an Australian pharmaceutical research company focussed on inflammation and fibrosis with a portfolio of products at various stages of development and approval. The Company's head office, manufacturing and research laboratories are located in Sydney, Australia.

Contact Details

Unit 2 , 20 Rodborough Rd FRENCHS FOREST NSW 2086
02 9454 7200
www.pharmaxis.com.au

Lists and Charts

Share price

Pharmaxis
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Revenue

Rank Company #
699th - Pharmaxis $19.19m
1331 public companies - non WA ranked by total revenue
View Full List

Company Share Transactions

29/11/23
Issued
Pharmaxis
02/12/22
Issued
Pharmaxis
02/12/22
Issued
Pharmaxis
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: J Baskar, 03 Jan 2023
NEW ROLE: Wolfgang Jarolimek, Head of Drug Discovery 24 Nov 2020
NEW ROLE: Kristen Morgan, Head of Medical Affairs 24 Nov 2020
NEW ROLE: WG Jarolimek, 24 Nov 2020
NEW ROLE: Kristen Morgan, Head of Medical Affairs 24 Nov 2020
REMUNERATION UPDATE: Niel Graham, Non-Executive Director 13 Nov 2020
Gary Phillips
REMUNERATION UPDATE: Gary Phillips, Chief Executive 13 Nov 2020
REMUNERATION UPDATE: Delaat Delaat, Non-Executive Director 13 Nov 2020
Malcolm McComas
REMUNERATION UPDATE: Malcolm McComas, Non-Executive Chair 13 Nov 2020

News Articles

Related Information

Access to our data for Pharmaxis is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Pharmaxis is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X